Correspondence 0001178913-25-001039 from TRINITY BIOTECH PLC (TRIB)

TRINITY BIOTECH PLC
Date: March 26, 2025 · CIK: 0000888721 · Accession: 0001178913-25-001039

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

March 26, 2025

Author

Chief Financial Officer

Form

CORRESP

Company

TRINITY BIOTECH PLC

Letter

Re: Trinity Biotech plc Registration Statement on Form F-3 File No. 333- 286020

TRINITY BIOTECH PLC

March 26, 2025

VIA EDGAR

U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549

Attention:

Daniel Crawford

To Mr. Crawford:

The undersigned, on behalf of Trinity Biotech plc (“Trinity”), issuer of the securities covered by the above-referenced Registration Statement, hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m. Eastern Time on Friday, March 28, 2025, or as soon thereafter as possible.

Please contact Steven Glusband (212-238-8605, glusband@clm.com) or Mary Brown (212-238-8765, mbrown@clm.com) of Carter Ledyard & Milburn LLP with any questions you may have concerning this request.

Very truly yours,
/s/ Louise Tallon
Louise Tallon
Chief Financial Officer

Show Raw Text

CORRESP
 1
 filename1.htm

 TRINITY BIOTECH PLC

 March 26, 2025

 VIA EDGAR

 U.S. Securities and Exchange Commission
 Division of Corporation Finance
 Office of Life Sciences
 100 F Street, NE
 Washington, D.C. 20549

 Attention:

 Daniel Crawford

 Re: Trinity Biotech plc
 Registration Statement on Form F-3
 File No. 333-   286020

 To Mr. Crawford:

 The undersigned, on behalf of Trinity Biotech plc (“Trinity”), issuer of the securities covered by the
 above-referenced Registration Statement, hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m. Eastern Time on Friday, March 28, 2025, or as soon
 thereafter as possible.

 Please contact Steven Glusband (212-238-8605, glusband@clm.com) or Mary Brown (212-238-8765, mbrown@clm.com) of
 Carter Ledyard & Milburn LLP with any questions you may have concerning this request.

 Very truly yours,

 /s/ Louise Tallon
 Louise Tallon
 Chief Financial Officer

SecProbe.io